WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial (Q44830897)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 1986
edit
Language Label Description Also known as
English
WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial
scientific article published in April 1986

    Statements

    WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit